Caffeine for treatment of Parkinson disease: A randomized controlled trial

Epidemiologic studies consistently link caffeine, a nonselective adenosine antagonist, to lower risk of Parkinson disease (PD). However, the symptomatic effects of caffeine in PD have not been adequately evaluated. We conducted a 6-week randomized controlled trial of caffeine in PD to assess effects...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurology 2012-08, Vol.79 (7), p.651-658
Hauptverfasser:	POSTUMA, Ronald B, LANG, Anthony E, CHUANG, Rosa, SHAH, Binit, MUNHOZ, Renato P, CHARLAND, Katia, PELLETIER, Amelie, MOSCOVICH, Mariana, FILLA, Luciane, ZANATTA, Debora, RIOS ROMENETS, Silvia, ALTMAN, Robert
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Biological and medical sciences Caffeine - therapeutic use Central Nervous System Stimulants - therapeutic use Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Fatigue - drug therapy Female Humans Male Medical sciences Middle Aged Neurology Parkinson Disease - drug therapy Quality of Life Severity of Illness Index Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!